SE

Thomas Lundqvist

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Lundqvist. Retrieved from https://idiyas.com/inventor/thomas-lundqvist-su6z6pt1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Thomas Lundqvist: Innovator in Transdermal Drug Delivery

Introduction

Thomas Lundqvist is a notable inventor based in Sweden. He has made significant contributions to the field of drug delivery systems. His innovative approach focuses on enhancing the effectiveness of transdermal drug administration.

Latest Patents

Thomas Lundqvist holds a patent for a transdermal drug administration device. This device comprises a drug delivery element that defines a contact surface for application against a patient's skin. The drug delivery element includes a sustained-release pharmaceutical composition. This composition consists of a network of a carrier material with high mechanical strength, interspersed with an active pharmaceutical ingredient.

Career Highlights

Thomas is currently associated with Emplicure AB, where he continues to develop innovative solutions in drug delivery. His work emphasizes the importance of effective and efficient medication administration.

Collaborations

Some of his notable coworkers include Hakan Engqvist and Susanne Bredenberg. Their collaborative efforts contribute to the advancement of drug delivery technologies.

Conclusion

Thomas Lundqvist is a dedicated inventor whose work in transdermal drug delivery systems showcases his commitment to improving healthcare solutions. His innovative device has the potential to enhance patient care significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…